CXR-101

N/A

Report date: 2025/09/08 13:19:33

Base Information

Drug NameCXR-101
Drug Alias NameCXR-101
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 inhibitors
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCorriXR Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesCorriXR Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A